Purpose The genomic characteristics of uterine sarcomas have not been fully elucidated. This study aimed to explore the genomic landscape of the uterine sarcomas (USs).
Materials and Methods Comprehensive genomic analysis through RNA-sequencing was conducted. Gene fusion, differentially expressed genes (DEGs), signaling pathway enrichment, immune cell infiltration, and prognosis were analyzed. A deep learning model was constructed to predict the survival of US patients.
Results A total of 71 US samples were examined, including 47 endometrial stromal sarcomas (ESS), 18 uterine leiomyosarcomas (uLMS), three adenosarcomas, two carcinosarcomas, and one uterine tumor resembling an ovarian sex-cord tumor. ESS (including high-grade ESS [HGESS] and low-grade ESS [LGESS]) and uLMS showed distinct gene fusion signatures; a novel gene fusion site, MRPS18A–PDC-AS1 could be a potential diagnostic marker for the pathology differential diagnosis of uLMS and ESS; 797 and 477 uterine sarcoma DEGs (uDEGs) were identified in the ESS vs. uLMS and HGESS vs. LGESS groups, respectively. The uDEGs were enriched in multiple pathways. Fifteen genes including LAMB4 were confirmed with prognostic value in USs; immune infiltration analysis revealed the prognositic value of myeloid dendritic cells, plasmacytoid dendritic cells, natural killer cells, macrophage M1, monocytes and hematopoietic stem cells in USs; the deep learning model named Max-Mean Non-Local multi-instance learning (MMN-MIL) showed satisfactory performance in predicting the survival of US patients, with the area under the receiver operating curve curve reached 0.909 and accuracy achieved 0.804.
Conclusion USs harbored distinct gene fusion characteristics and gene expression features between HGESS, LGESS, and uLMS. The MMN-MIL model could effectively predict the survival of US patients.
Citations
Citations to this article as recorded by
An interpretable model based on weakly supervised learning for uterine smooth muscle tumor diagnosis: A multi-center study Xiaoxi Wang, Xiaochen Shen, Moxuan Yang, Ling Yang, Ying He, Yanni Ren, Shuhao Wang, Dayi Wu, Yuanyuan Guo, Yiru Niu, Kaiyue Peng, Zhihui Wang, Jingpeng Wu, Jiacheng Li, Wei Wang, Feng Wang, Lijuan Cui, Wei Wang, Congrong Liu, Dingrong Zhong Pathology - Research and Practice.2026; 278: 156337. CrossRef
Integrated mutational landscape analysis of endometrial stromal sarcoma Tobias M. P. Hartwich, Seungji Choi, Ayoung Hwang, Stefania Bellone, Luca Palmieri, Hae Seo, Taekeun Kim, Juhyeon Hong, Camilla Krakstad, Jone Trovik, Ingunn M. Stefansson, Hans Kristian Haugland, Michelle Greenman, Victoria Ettorre, Sarah Ottum, Cem Demi Proceedings of the National Academy of Sciences.2026;[Epub] CrossRef
Mitochondrial Ribosomal Proteins and Cancer Huiyi Wu, Xiaowei Zhu, Huilin Zhou, Min Sha, Jun Ye, Hong Yu Medicina.2025; 61(1): 96. CrossRef
Molecular Insights in Endometrial Stromal Sarcomas: Exploring New Targets for Novel Therapeutic Approaches Alice Costa, Annalisa Astolfi, Livia Gozzellino, Margherita Nannini, Gianandrea Pasquinelli, Maria Abbondanza Pantaleo Biomolecules.2025; 15(2): 265. CrossRef
Uncertainty-driven hybrid-view adaptive learning for fully automated uterine leiomyosarcoma diagnosis Qi Li, Jingxian Wu, Xiyu Liu, Dengwang Li, Jie Xue Medical Image Analysis.2025; 105: 103692. CrossRef
2.5D deep learning radiomics and clinical data for predicting occult lymph node metastasis in lung adenocarcinoma Xiaoxin Huang, Xiaoxiao Huang, Kui Wang, Haosheng Bai, Xiuxian Lu, Guanqiao Jin BMC Medical Imaging.2025;[Epub] CrossRef
A four-gene signature identified by integrated transcriptomic analysis for differential diagnosis and prognosis of uterine smooth muscle tumors Huiyi Hu, Yuanqun Chen, Bo Hong, Jia Liu, Yuchen Jiang, Zhiying Yu, Zhi-Jie Xiao, Jing Li Frontiers in Oncology.2025;[Epub] CrossRef
Purpose C5α receptor 1 (C5ΑR1) is associated with the development of various human cancers. However, whether it is involved in the development of hepatitis B virus (HBV)–related hepatocellular carcinoma (HCC) is poorly understood. We explored the expression, biological role, and associated mechanisms of C5AR1 in HBV-related hepatoma cells.
Materials and Methods The expression of C5ΑR1 mediated by HBV and HBV core protein (HBc) was detected in hepatoma cells. The function of nuclear factor кB (NF-κB) pathway in HBc-induced C5AR1 expression was assessed. The roles of C5ΑR1 in the activation of intracellular signal pathways, the upregulation of inflammatory cytokines, and the growth and migration of hepatoma cells mediated by HBc, were investigated. The effect of C5α in the development of HCC mediated by C5AR1 was also measured.
Results C5ΑR1 expression was increased in HBV-positive hepatoma cells. Dependent on HBc, HBV enhanced the expression of C5ΑR1 at the mRNA and protein levels. Besides, HBc could promote C5ΑR1 expression via the NF-κB pathway. Based on the C5ΑR1, HBc facilitated the activation of JNK and ERK pathways and the expression and secretion of interleukin-6 in hepatoma cells. Furthermore, C5ΑR1 was responsible for enhancing the growth and migration of hepatoma cells mediated by HBc. Except these, C5α could promote the malignant development of HBc-positive HCC via C5AR1.
Conclusion We provide new insight into the mechanisms of hepatocarcinogenesis mediated by HBc. C5ΑR1 has a significant role in the functional abnormality of hepatoma cells mediated by HBc, and might be utilized as a potential therapeutic target for HBV-related HCC.
Citations
Citations to this article as recorded by
Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB Peili Hou, Hongchao Zhu, Fengyun Chu, Yan Gao, Xiaonan Sun, Fuzhen Zhang, Xiaomeng Wang, Yueyue Feng, Xingyu Li, Yu Liu, Jun Wang, Xiaoyun Wang, Daniel Chang He, Hongmei Wang, Hongbin He Nature Communications.2025;[Epub] CrossRef
HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression Fanyun Kong, Ensi Bao, Yujie Zhong, Yuxin Wang, Ruyu Liu, Huanyang Zhang, Lu Yang, Rong Jiang, Xuanke Liu, Chen Li, Xiangye Liu, Xiucheng Pan, Kuiyang Zheng, Hongjuan You, Renxian Tang Hepatology Communications.2025;[Epub] CrossRef
Transcriptional regulation of tumor suppressor gene RASSF1A by HBx Yanhong Kang, Wei Li, Junfeng Wei, Lin Yang, Yi Kang Molecular and Cellular Probes.2025; 82: 102034. CrossRef
Hepatitis B virus core protein promotes liver cancer progression by stabilizing CANX and suppressing IRF7 transcription Hong-juan You, Huan-yang Zhang, Yu-jie Zhong, Ru-yu Liu, Lu Yang, Rong Jiang, Yu-xin Wang, En-si Bao, Xiang-ye Liu, Chen Li, Xiu-cheng Pan, Xu-feng Huang, Kui-yang Zheng, Ren-xian Tang, Fan-yun Kong Acta Pharmacologica Sinica.2025; 46(11): 3036. CrossRef
Effects of interleukin‑6 genetic variation on hepatitis B virus infection and susceptibility to hepatocellular carcinoma: A systematic review and meta‑analysis Bibin Antony, Karthikeyan Murugesan, Anjuna Radhakrishnan, Yupa Min, Gowtham Subbaraj World Academy of Sciences Journal.2025; 7(4): 1. CrossRef
Understanding the role of C5a/C5aR1-mediated complement activation pathway in tumor progression and therapy resistance Lemei Zheng, Jianxia Wei, Mengna Li, Changning Xue, Qingqing Wei, Zubing Wu, Xiaolong Li, Ting Zeng, Huizhen Xin, Wei Xiong, Hongyu Deng, Ming Zhou Science China Life Sciences.2025;[Epub] CrossRef
Bioinformatics analysis reveals C5AR1’s impact on thyroid cancer development via immune infiltration Yueyao Sun, Lei Xu, Xiaowen Ma, Haobo Wang, Zihao Li, Ji Feng, Tongtong Ji, Qi Wang, Bo Liu, Fangjian Shang Scientific Reports.2025;[Epub] CrossRef
Colchicine-mediated selective autophagic degradation of HBV core proteins inhibits HBV replication and HBV-related hepatocellular carcinoma progression Hui Zhang, Xiameng Su, Leirong Gu, Ming Tan, Yuting Liu, Kexin Xu, Jihua Ren, Juan Chen, Zhihong Li, Shengtao Cheng Cell Death Discovery.2024;[Epub] CrossRef
Hepatitis B virus X protein increases LASP1 SUMOylation to stabilize HER2 and facilitate hepatocarcinogenesis Hongjuan You, Dongchen Yuan, Qi Li, Ning Zhang, Delong Kong, Tong Yu, Xiangye Liu, Xiaomei Liu, Rui Zhou, Fanyun Kong, Kuiyang Zheng, Renxian Tang International Journal of Biological Macromolecules.2023; 226: 996. CrossRef
PLK3 promotes the proneural–mesenchymal transition in glioblastoma via transcriptional regulation of C5AR1 Shuo Yu, Lin Lv, Yang Li, Qian Ning, Tingting Liu, Tinghua Hu Molecular Biology Reports.2023; 50(10): 8249. CrossRef
The role of UXT in tumors and prospects for its application in hepatocellular carcinoma Zhengwang Wang, Shaojian Mo, Pengzhe Han, Lu Liu, Ziang Liu, Xifeng Fu, Yanzhang Tian Future Oncology.2022; 18(29): 3335. CrossRef
C5aR1 promotes the progression of colorectal cancer by EMT and activating Wnt/β-catenin pathway Duo Xu, Meirong Li, Longyan Ran, Xiaochen Li, Xingwang Sun, Tao Yin Clinical and Translational Oncology.2022; 25(2): 440. CrossRef
The Complement System: A Potential Therapeutic Target in Liver Cancer Meng Yuan, Li Liu, Chenlin Wang, Yan Zhang, Jiandong Zhang Life.2022; 12(10): 1532. CrossRef
A Pleiotropic Role of the Hepatitis B Virus Core Protein in Hepatocarcinogenesis Caroline Lefeuvre, Hélène Le Guillou-Guillemette, Alexandra Ducancelle International Journal of Molecular Sciences.2021; 22(24): 13651. CrossRef
A 61-year-old male patient was simultaneously diagnosed with lung adenocarcinoma and inflammatory myofibroblastic tumor (IMT). The lung adenocarcinoma and IMT harbored two distinct types of ALK translocation, LOC101927285-ALK, and TPM3-ALK, respectively. The ALK Ventana showed strong positivity on both lesions. The patient was therefore given an endobronchial cryotherapy and ALK inhibitor crizotinib. The tumors showed durable response however the left lung adenocarcinoma relapsed at 17th month post-crizotinib treatment. Tissue re-biopsy on the resistant tumor revealed an ALK exon 23 C1156Y missense mutation in addition to LOC101927285-ALK mutation. Further RNA-based sequence uncovered that the noncoding region rearrangement is the fusion mutation of EML4-ALK. The patient was therefore received alectinib, and the tumor exhibited partly response. Overall, it is very rare that two types of pulmonary tumors exist in one patient driven by two distinct ALK fusions, which emphasizes the necessity of gene sequencing in clinical decision-making and individualized therapy.
Citations
Citations to this article as recorded by
TTC7A-ALK, a novel ALK fusion variant identified in a patient with metastatic lung adenocarcinoma, exhibits excellent response to crizotinib Meijin Huang, Xiangqing Zhu, Wenmang Xu, Jun Zhu, Xin Xun, Bin Su, Hong Chen Translational Oncology.2025; 54: 102345. CrossRef
Clinicopathological analysis of 18 cases of inflammatory myofibroblastic tumor in oral and maxillofacial region Wei Li, Meng-chen Li, Zi-xuan Fan, Zi-chen Cao, Jie Yang, Xu-dong Yang, Xiao-feng Huang BMC Oral Health.2025;[Epub] CrossRef
Retroperitoneal invasive fibromatosis after laparoscopic radical resection of colon cancer: a case report and literature review Tiantian Shan, Yiqi Zhang, Yang Yao, Min Li, Xiaoying Li Frontiers in Oncology.2025;[Epub] CrossRef
Successful treatment of a non‐small‐cell lung cancer patient harboring HIP1‐ALK (H28:A20) and CTNNB1 p.S45del with alectinib Vito Longo, Francesco Pesola, Rosanna Lacalamita, Annamaria Catino, Michele Montrone, Ilaria Marech, Pamela Pizzutilo, Elisabetta Sara Montagna, Stefania Tommasi, Domenico Galetta Thoracic Cancer.2024; 15(31): 2283. CrossRef
Coexistence of a novel SV2B-ALK, EML4-ALK double-fusion in a lung poorly differentiated adenocarcinoma patient and response to alectinib: a case report and literature review Huang Chen, Menglan Zhang, Liyan Bai, Yun Niu, Xiaowei Wang, Ruiying Jiang, Ye Wang, Qianqian Feng, Bei Wang, Tingli Dai, Mingming Yuan, Rongrong Chen, Yujuan Qi, Dingrong Zhong Frontiers in Oncology.2024;[Epub] CrossRef
Novel treatment of endobronchial inflammatory myofibroblastic tumor in a child Jessica Reyes‐Angel, Louis B. Rapkin, Jeffrey P. Simons, Hiren Muzumdar Pediatric Pulmonology.2022; 57(1): 330. CrossRef
Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer Yan Xiang, Shiyu Zhang, Xiaoxu Fang, Yingying Jiang, Tingwen Fang, Jinwen Liu, Kaihua Lu Current Oncology.2022; 29(10): 7816. CrossRef
Crizotinib in Sarcomatous Malignancies Harboring ALK Fusion With a Definitive Partner(s): Response and Efficacy Jinchun Wu, Yongbin Hu, Omar Abdihamid, Gengwen Huang, Sheng Xiao, Bin Li Frontiers in Oncology.2021;[Epub] CrossRef
Purpose
Whether craniospinal irradiation (CSI) could be replaced by limited-field radiation in non-metastatic bifocal germinoma remains controversial. We addressed the issue based on the data from our series and the literature.
Methods
Data from 49 patients diagnosed with non-metastatic bifocal germinoma at our hospital during the last 10 years were collected. The Pediatric Quality of Life Inventory 4.0 was used to evaluate health-related quality of life (HRQOL). Additionally, 81 patients identified from the literature were also analyzed independently.
Results
In our cohort, 34 patients had tumors in the sellar/suprasellar (S/SS) plus pineal gland (PG) regions and 15 in the S/SS plus basal ganglia/thalamus (BG/T) regions. The median follow-up period was 52 months (range, 10 to 134 months). Our survival analysis showed that patients treated with CSI (n=12) or whole-brain radiotherapy (WBRT; n=34) had comparable disease-free survival (DFS; p=0.540), but better DFS than those treated with focal radiotherapy (FR; n=3, p=0.016). All 81 patients from the literature had tumors in the S/SS+PG regions. Relapses were documented in 4/45 patients treated with FR, 2/17 treated with whole-ventricle irradiation, 0/4 treated with WBRT, and 1/15 treated with CSI. Survival analysis did not reveal DFS differences between the types of radiation field (p=0.785). HRQOL analysis (n=44) in our cohort found that, compared with S/SS+PG germinoma, patients with BG/T involvement had significantly lower scores in social and school domains. However, HRQOL difference between patients treated with CSI and those not treated with CSI was not significant.
Conclusion
In patients with non-metastatic bifocal germinoma, it is rational that CSI could be replaced by limited-field radiation. HRQOL in patients with BG/T involvement was poorer.
Citations
Citations to this article as recorded by
Long-term intelligence after high-dose radiotherapy to the primary site versus chemotherapy and whole-ventricle radiotherapy in patients with germinoma Masayuki Kanamori, Yumi Sugawara, Yoshiteru Shimoda, Osamu Iizuka, Yoshinari Osada, Shota Yamashita, Ichiyo Shibahara, Rei Umezawa, Naoko Mori, Ryuta Saito, Yukihiko Sonoda, Toshihiro Kumabe, Keiichi Jingu, Shunji Mugikura, Kyoko Suzuki, Hidenori Endo International Journal of Clinical Oncology.2026;[Epub] CrossRef
A systematic review and meta-analysis of x-ray therapy versus proton beam therapy for pediatric central nervous system germ cell tumors: TRP-Germinoma 2025 Sho Hosaka, Masashi Mizumoto, Hiroko Fukushima, Takashi Iizumi, Takashi Saito, Masako Inaba, Ryoko Suzuki, Yinuo Li, Kei Nakai, Shosei Shimizu, Yoshiko Oshiro, Kazushi Maruo, Hidetoshi Takada, Hideyuki Sakurai International Journal of Clinical Oncology.2025; 30(10): 1906. CrossRef
Retrospective investigation of hereditary syndromes in patients with medulloblastoma in a single institution Ying Wang, Jingchuan Wu, Wei Li, Jiankang Li, Raynald Liu, Bao Yang, Chunde Li, Tao Jiang Child's Nervous System.2021; 37(2): 411. CrossRef
Molecular Pathology and Targeted Therapies for Personalized Management of Central Nervous System Germinoma Cristina Ilcus, Horatiu Silaghi, Carmen Emanuela Georgescu, Carmen Georgiu, Anca Ileana Ciurea, Simona Delia Nicoara, Cristina Alina Silaghi Journal of Personalized Medicine.2021; 11(7): 661. CrossRef
Basal Ganglia Germ Cell Tumors With or Without Sellar Involvement: A Long-Term Follow-Up in a Single Medical Center and a Systematic Literature Review Yi Zhang, Li Wang, Wenbin Ma, Hui Pan, Renzhi Wang, Huijuan Zhu, Yong Yao Frontiers in Endocrinology.2021;[Epub] CrossRef